Integrated Filing — IndAS


General information about company

Scrip Code 506618
NSE Symbol PUNJABCHEM
MSEI Symbol NOTLISTED
ISIN INE277B01014
Name of company Punjab Chemicals & Crop Protection Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 30-Apr-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 19-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Performance Chemicals
Start date and time of board meeting 30-Apr-2025   13:00:00
End date and time of board meeting 30-Apr-2025   14:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-01-28
Indicate Company website link for updated RPT policy of the Company www.punjabchemicals.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? Yes



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 2014700000 8983800000
Other income 3500000 12100000
Total income 2018200000 8995900000
2 Expenses
(a) Cost of materials consumed 1538100000 5873700000
(b) Purchases of stock-in-trade 4100000 30700000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -399100000 -527100000
(d) Employee benefit expense 233800000 950900000
(e) Finance costs 47500000 178300000
(f) Depreciation, depletion and amortisation expense 64200000 248000000
(f) Other Expenses
1 Other Expenses 387300000 1663100000
Total other expenses 387300000 1663100000
Total expenses 1875900000 8417600000
3 Total profit before exceptional items and tax 142300000 578300000
4 Exceptional items -41800000 -41800000
5 Total profit before tax 100500000 536500000
6 Tax expense
7 Current tax 35000000 136300000
8 Deferred tax -9100000 2500000
9 Total tax expenses 25900000 138800000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 74600000 397700000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 74600000 397700000
17 Other comprehensive income net of taxes -200000 -2400000
18 Total Comprehensive Income for the period 74400000 395300000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 122600000 122600000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 3720800000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 6.08 32.44
Diluted earnings (loss) per share from continuing operations 6.08 32.44
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 6.08 32.44
Diluted earnings (loss) per share from continuing and discontinued operations 6.08 32.44
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results i) The above standalone financial results for the year ended March 31, 2025 as reviewed by the Audit nCommittee and have been approved by the Board of Directors at their meeting held on April 30, 2025. The naudit report of the Statutory Auditors is being filed with the BSE and National Stock Exchange. For more ndetails, visit the Investor section of our website at www.punjabchemicals.com and Financial Results at the ncorporate section of www.bseindia.com and www.nseindia.com. n nii) These results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed nunder Section 133 of the Companies Act, 2013 read with the relevant rules thereunder and in terms of nRegulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015. n niii) The Company is engaged in the single operating segment Performance Chemicals. n niv) The figures for the last quarter ended March 31, 2025 and the corresponding quarter ended in the previous nyear, are the balancing figures between audited figures in respect of the full financial year and the published, nyear to date, figures up to the end of third quarter of the relevant financial year. Also, the figures up to the end nof the third quarter had only been reviewed and not subject to audit. n nv) The Board has recommended a dividend of Rs.3/- (30%) per equity share of Rs. 10 each fully paid up namounting to Rs. 368 lakhs, subject to approval in the Annual General Meeting. n nvi) During the year, the Company has received demand order from Department of Goods and Services tax n(Government of Masharashtra) office of the Dy. commissioner of state tax relating to FY 2019-20 of Rs. 769 nlakhs including interest and penalty on account of non-payment of Goods and Service Tax on transfer of nleasehold right by the Company in that year. Company, after taking view of the their legal counsel has decided nto avail benefit of Amnesty Scheme u/s 128A of CGST Act, 2017 and paid Rs. 418 lakhs towards full and nfinal settlement of the above demand order. Considering the amount being material for the interim period, the nsame has been shown as exceptional item in the statement of profit and loss. n



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 2487800000
Capital work-in-progress 130200000
Investment property 0
Goodwill 0
Other intangible assets 26500000
Intangible assets under development 10400000
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 15700000
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 47100000
Total non-current financial assets 62800000
Deferred tax assets (net) 0
Other non-current assets 53000000
Total non-current assets 2770700000
2 Current assets
Inventories 2223700000
Current financial asset
Current investments 22600000
Trade receivables, current 2513300000
Cash and cash equivalents 127000000
Bank balance other than cash and cash equivalents 49400000
Loans, current 208700000
Other current financial assets 210800000
Total current financial assets 3131800000
Current tax assets (net) 0
Other current assets 216900000
Total current assets 5572400000
3 Non-current assets classified as held for sale 3000000
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 8346100000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 122600000
Other equity 3720800000
Total equity attributable to owners of parent 3843400000
Non controlling interest
Total equity 3843400000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 697700000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 0
Total non-current financial liabilities 697700000
Provisions, non-current 128000000
Deferred tax liabilities (net) 80600000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 906300000
Current liabilities
Current financial liabilities
Borrowings, current 981200000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 107800000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1901100000
Total Trade payable 2008900000
Other current financial liabilities 439400000
Total current financial liabilities 3429500000
Other current liabilities 40900000
Provisions, current 50200000
Current tax liabilities (Net) 75800000
Deferred government grants, Current 0
Total current liabilities 3596400000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 4502700000
Total equity and liabilites 8346100000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Amount of item that will not be reclassified to profit and loss -400000 -3300000
Total Amount of items that will not be reclassified to profit and loss -400000 -3300000
2 Income tax relating to items that will not be reclassified to profit or loss -200000 -900000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -200000 -2400000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 536500000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 178300000
Adjustments for decrease (increase) in inventories -897100000
Adjustments for decrease (increase) in trade receivables, current -433700000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -52300000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current -74400000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 838700000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 248000000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current -3800000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 7800000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -6200000
Adjustments for dividend income 0
Adjustments for interest income 5500000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) -2300000
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -202500000
Net cash flows from (used in) operations 334000000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 107700000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 226300000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 3100000
Purchase of property, plant and equipment 315000000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 6600000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 23800000
Net cash flows from (used in) investing activities -281500000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 487900000
Repayments of borrowings 124400000
Payments of lease liabilities 35300000
Dividends paid 36400000
Interest paid 171300000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 120500000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 65300000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 65300000
Cash and cash equivalents cash flow statement at beginning of period 61700000
Cash and cash equivalents cash flow statement at end of period 127000000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 BSR and Co. LLP Yes 31-Jul-2025


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Punjab chemicals and Crop Protection Limited SD Agchem Europe NV Subsidiary Sale of goods or services 111800000 Approved 111800000 0 0
2 Punjab chemicals and Crop Protection Limited SD Agchem Europe NV Subsidiary Any other transaction Payable 0 NA 0 157100000 155300000
3 Punjab chemicals and Crop Protection Limited SD Agchem Europe NV Subsidiary Any other transaction Receivable 0 NA 0 187400000 178700000
4 Punjab chemicals and Crop Protection Limited SD Agchem Europe NV Subsidiary Any other transaction Advance given 0 NA 0 210000000 207600000
5 Punjab chemicals and Crop Protection Limited Shroff Family Master Trust Entities with joint control or significant influence over entity Any other transaction Lease Liablities 5500000 Approved 5500000 0 0
6 Punjab chemicals and Crop Protection Limited Salil Shroff HUF Entities with joint control or significant influence over entity Any other transaction Lease Liablities 900000 Approved 900000 0 0
7 Punjab chemicals and Crop Protection Limited Malvika Gupta Relatives of Key Managerial Personnel Any other transaction Lease Liablities 3100000 Approved 3100000 0 0
8 Punjab chemicals and Crop Protection Limited Hem-sil Trading and Manufacturing Private Limited Promoter Group Interest paid 9100000 Approved 9100000 162600000 166500000 Loan 0.115 3 Years Unsecured Loan renewed and tenure extended for next three years
9 Punjab chemicals and Crop Protection Limited Shalil Shashikumar Shroff Promoter and KMP Remuneration 9400000 Approved 9400000 4700000 10600000
10 Punjab chemicals and Crop Protection Limited Vinod Kumar Gupta KMP Remuneration 14600000 Approved 14600000 0 2700000
11 Punjab chemicals and Crop Protection Limited Ashish R Nayak KMP Remuneration 3300000 Approved 3300000 0 0
12 Punjab chemicals and Crop Protection Limited Rishu Chatley KMP Remuneration 1500000 Approved 1500000 0 0
13 Punjab chemicals and Crop Protection Limited Vikash Khanna KMP Remuneration 200000 Approved 200000 0 0
14 Punjab chemicals and Crop Protection Limited Jaskaran Singh Relative of Director Remuneration 1300000 Approved 1200000 0 0
15 Punjab chemicals and Crop Protection Limited Shivshankar Shripal Tiwari Director Any other transaction Legal and Professional fees paid and payable 1600000 Approved 1600000 0 1500000
16 Punjab chemicals and Crop Protection Limited Sonal Tiwari Relative of Director Any other transaction Legal and Professional fees paid and payable 1700000 Approved 1700000 0 400000
17 Punjab chemicals and Crop Protection Limited Sitting fees and Commission to Non Executive Directors Directors Any other transaction Sitting Fees and Commission 700000 Approved 700000 2500000 4200000
18 Punjab chemicals and Crop Protection Limited Post Employment benefits to KMPs KMP Any other transaction Post Employment benefits to KMPs 3200000 Approved 3200000 0 0
Total value of transaction during the reporting period 167800000





Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date 0
B Of the total amount outstanding, amount of default as on date 0
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date 0
B Of the total amount outstanding, amount of default as on date 0
3. Total financial indebtedness of the listed entity including short-term and long-term debt 0